IL6 and COVID-19: This finding seems to be in line with what has been reported for other chronic inflammatory olfactory dysfunctions [19, 20] but, considering that high levels of IL-6 are a well-established negative prognostic factor [16–18], it would be in contrast to the fact that olfactory disorders seem to represent a favorable prognostic index in COVID-19 patients [10–13].